Limb lengthening, answered

In published case series, internal-nail PRECICE 2 tends to have a lower total complication rate than LON, mostly because LON adds pin-site infection risk on top of the same core surgery. Any-complication figures across cosmetic-lengthening series sit broadly in the 30–45% band with serious complications far rarer, and the gap between the two methods narrows substantially when both are performed by high-volume surgeons.

It is real surgery with a genuine complication rate: a 131-patient cosmetic series reported 37% overall complications, most manageable and a smaller share serious, and a 795-patient review found serious major complications uncommon. Safety depends heavily on the surgeon's experience and the method, which is why choosing carefully matters more than the country or the implant.

Possible with LON in Turkey (Yurttaş, Buldu, others). Outside Turkey most surgeons decline because operating on both bones at once exposes you to the complication risk of each segment simultaneously, so your overall chance of a complication is meaningfully higher than for a single bone. Total time off feet runs 12–14 weeks for combined surgery.

There is no violent break, but there is real pain from the surgery and the daily lengthening, which is managed with medication and eases through recovery. Discomfort is sharpest in the early post-operative days and during active distraction, then gradually settles. It is a controlled process, not a traumatic fracture, but it is not painless.

Surgeons make a precise, planned cut in the femur or tibia (an osteotomy), often dividing mainly the outer shell of the bone to protect its blood supply. A lengthening device, either an internal magnetic nail or an external fixator, then pulls the two ends apart about 1 mm a day so new bone can grow in the gap.

Many surgeons use a corticotomy, cutting mainly the hard outer shell (cortex) of the bone while protecting the inner blood supply and the surrounding membrane that drives healing. It is a controlled division designed to heal predictably, not a complete traumatic break of the whole bone.

Because femur-only delivers 6–8 cm — already at most patients' target height. Many patients also describe a different attitude toward the second surgery after living through the first: the recovery is shorter than expected from the outside but longer than expected from the inside.

A modern external fixator built around a hexapod structure (six adjustable struts). It can correct three-plane deformities more precisely than the original Ilizarov apparatus. Used at HSS, Paley Institute and Rubin Institute for complex reconstructive cases.

Lower labour and hospital costs in Turkey/Iran/India, no FDA/CE-marked premium implant fee (LON uses a standard interlocking nail plus a generic external fixator), and lower medico-legal premiums. The clinical difference is smaller than the price difference.

A single lengthening realistically adds about 5 to 8 cm in the femur or 5 to 7 cm in the tibia, with a mean of 6.7 cm across a 795-patient systematic review. Larger totals require two separate stages and bring bigger recovery and proportion trade-offs.

Standard is 12–18 months. The interval is set by bone biology — the femur must reach full consolidation and the patient must complete implant removal before starting the tibia. Shorter intervals raise refracture risk on the already-lengthened femur.

For cosmetic limb lengthening: yes, on published complication rates. For reconstructive cases with deformity, length discrepancy or large gains (>8 cm): no — the external fixator's three-dimensional control can be the safer option clinically.

Yes. Both methods leave the same two 1–3 cm incisions at hip and knee, but LON adds 6–10 small pin-site punctures per leg that distribute along the lateral thigh. Pin marks fade significantly over 12–24 months but remain visible up close.

Because some clinical situations (large gains, deformity correction, pediatric cases, segment transport) cannot be solved with an internal nail. The Ilizarov apparatus remains the most flexible reconstructive tool in orthopaedics.

That is the question every patient is implicitly answering. The clinical gap is real but smaller than the price gap. Most patients in budget-constrained situations get good outcomes with LON when they pick a high-volume surgeon.

PRECICE 2 and PRECICE Max for cosmetic cases. The Paley Institute led the first US PRECICE Max surgery in December 2023. LON is offered for reconstructive indications where the external fixator capability is clinically needed.

Yes, in most published patient reports. The tibia has thin anterior soft-tissue cover, so the soft-tissue stretch is felt more sharply. Pin-site infections also run 15–30% in tibial LON/Ilizarov vs 5–15% in the femur.

Three reasons: the femur tolerates more length in one stage (6–8 cm vs 5–7 cm for the tibia), recovers faster despite being the larger bone, and gives the proportional change most cosmetic patients are paying for.

Not in pure-Ilizarov protocols — the frame stays on through both distraction and consolidation. In hybrid LON, the fixator comes off after 8–10 weeks once distraction ends, and the internal nail handles the rest.

About 12–14 cm total in published series (7–8 cm femur + 5–6 cm tibia). Claims above 14 cm are exceptional cases and almost always involve a third stage or push the soft-tissue envelope beyond standard limits.

Yes. Wanna Be Taller, AFA, Yurttaş and others offer both methods. PRECICE 2 packages in Turkey typically run $35,000–$60,000 — still cheaper than the US but not by enough to fully close the value gap with LON.

Yes. PRECICE 2 and PRECICE Max are removed in a short second surgery at 12–18 months post-op once the new bone is fully consolidated. Add $2,000–$8,000 to your total budget for the removal.

Pure Ilizarov: 6–12 months (distraction + consolidation). LON hybrid: 8–10 weeks (distraction only).

No — the Stryde, a weight-bearing magnetic lengthening nail made from a stainless-steel alloy, was subject to an FDA Class I recall in April 2021 after retrieved implants showed corrosion at the telescoping junction along with focal bone changes and pain. It is no longer marketed. Modern internal lengthening uses the titanium PRECICE 2 or PRECICE Max instead. Our PRECICE Stryde recall explainer covers the timeline and what it means for patients.

Reputable centers require full skeletal maturity (generally 18 or older), good general health as a non-smoker — conditions that impair healing, such as poorly controlled diabetes, can disqualify — realistic expectations, the financial capacity to absorb a complication, and a psychological evaluation to rule out untreated body-image disorder. Being well-informed and motivated matters as much as the bone anatomy.

It depends on the job. Desk or remote work is often possible within a few weeks, once the surgical wounds heal and you are comfortable moving on crutches, while physically demanding work usually waits until full weight-bearing and bone consolidation — several months. Plan for meaningful time off and a graded return rather than an immediate one.

A single femur or tibia lengthening typically adds about 5–8 cm — roughly 2–3 inches. A two-stage plan (femur then tibia, in separate operations) can reach about 13–16 cm in total, or roughly 5–6 inches, at the upper end and with more cost, time, and risk. Claims of gaining 10 inches in one surgery are not realistic.

Full recovery typically takes about 9–12 months and can extend toward two years. Patients are mobilized early with assistance rather than confined to bed; full weight-bearing returns roughly 1–2 months after the lengthening phase ends (sooner for the femur, later for the tibia), with daily physiotherapy throughout.

A realistic before-and-after shows a permanent height increase of about 5–8 cm from one surgery, or up to roughly 13–16 cm from a two-stage plan. The change is proportionate and real, but it is not the dramatic one-operation transformation that marketing galleries imply, and the two photos are 12–18 months apart.

India and Turkey are the lowest-cost mainstream destinations (from roughly $6,000 in India for an external fixator and $20,000 in Turkey for LON), versus $84,000–$220,000 in the USA. Cheapest up front is not always cheapest overall — confirm what physiotherapy, follow-up, and hardware removal are included.

Some are, but they are marketing first. Galleries show cherry-picked best cases and often use posture, footwear, lighting, and camera angle to flatter the after image. Patients with complications or low-end results are not shown. Read them as advertising and ask the surgeon for the full range of outcomes.

Cosmetic lengthening is generally done between 18 (skeletal maturity) and the mid-40s. It is technically possible later, but complication risk rises with age — adults in their 30s had roughly twice, and those in their 50s about 2.6 times, the complication risk of teenagers in the best internal-nail data.

For someone with realistic expectations, a budget that survives a complication, and no untreated body-image disorder, published evidence shows high satisfaction and a permanent 6–7 cm gain. If the real driver is psychological distress, it is far more likely to disappoint — address that first.

Yes — it lengthens the legs only, so the torso stays the same and the leg-to-torso ratio shifts. For a modest gain this is invisible within normal variation; at the upper end of a two-stage plan it is more noticeable, which is worth picturing honestly before committing.

Death is very rare, but serious complications are not: about 9% of patients had permanent sequelae and ~9% of limbs had nerve injury in published cohorts. The biggest danger factors are a low-volume surgeon, an unaccredited facility, and skipped physiotherapy.

Not directly. The bone biology of distraction works at any adult age. What changes is the recovery time and consolidation speed — slower in older patients. The target gain may need to be more conservative in 45+ patients to keep the recovery window manageable.

Typically 12 to 18 months. The before is taken around surgery, and a genuine after is taken once distraction, consolidation, and physiotherapy are complete and the patient has returned to normal activity. A short gap suggests the result is not yet final.

About 5–8 cm from a single femur or tibia lengthening (a systematic review put the average near 67 mm), and up to roughly 13–16 cm from a two-stage femur-and-tibia plan at the upper end. Claims of 10 inches from one operation are not realistic.

No FDA-mandated upper age limit. The device is cleared for adults with closed growth plates. Surgeon-level age limits are the operative ones — most cap cosmetic use at 45-50, but case-by-case approvals into the 50s exist at major centers.

In uncomplicated cases, return to sport can begin around 6 months and full activity once the bone fully consolidates. High-impact performance (sprinting, dunking) depends on the individual, the gain, and the quality of rehabilitation.

No. Every major insurer and health system classifies cosmetic stature lengthening as elective and excludes it. Coverage applies only to medically indicated lengthening (congenital discrepancy, post-trauma shortening, achondroplasia).

Realistically 5–8 cm (about 2–3 inches) per bone segment; the largest review reported a mean gain of 6.7 cm. Patients who lengthen both femur and tibia in two stages can reach more, but each additional centimeter raises the risk.

The standard distraction rate is 1 mm per day, usually divided into four 0.25 mm turns. That gives roughly 1 cm every 10 days. A 6 cm gain takes about 60 days of active distraction, followed by 3-6 months of consolidation.

Yes, especially during distraction and physiotherapy. Internal-nail methods are generally more comfortable than external fixators, but pain and stiffness through the recovery year are expected and managed, not avoided.

Most reputable surgeons require closed growth plates, which usually means 17-18 in females and 19-21 in males. Some clinics accept 16-17 with pediatric orthopedic oversight and confirmed skeletal maturity on imaging.

Most patients at experienced centers regain function and report satisfaction, but "fully" is individual. Range-of-motion and strength outcomes hinge on physiotherapy, and a minority are left with permanent effects.

Yes, but case-by-case. A fit non-smoker with healthy joints can be a candidate into the 50s. An MRI of knees and hips, a DEXA bone-density scan, and a thorough cardiovascular workup are standard before scheduling.

Yes if you are under 21. Standard screening includes hand-and-wrist bone-age radiographs and dedicated imaging of the distal femur and proximal tibia growth plates. Surgery requires documented closure.

PRECICE 2 linear scars fade to barely visible silver lines by 18-24 months. LON and Ilizarov pin-site scars fade significantly by 2 years but remain locatable indefinitely as a faint dot pattern.

A complete two-stage cosmetic plan (femur first, tibia 12-18 months later) realistically adds 11 to 15 cm. The most aggressive plans reach 16 cm, which is the upper bound across two operations.

Not at a 6 cm single-stage gain. At a two-stage 13-16 cm gain, the leg-to-torso ratio shift becomes visible. Ask your surgeon for a projected silhouette mock-up before committing to a target.

Only with the Ilizarov method, and only in the femur, and at a complication cost most cosmetic patients would not accept. The realistic single-surgery ceiling is 8 cm with PRECICE 2 or LON.

The tibia has less soft-tissue envelope around the bone and the peroneal nerve is more vulnerable to traction. Surgeons cap tibia gain around 5-7 cm to keep nerve injury rates acceptable.

At 24 months, most observers cannot see PRECICE 2 femur scars unless they know to look. PRECICE 2 tibia scars at the ankle are more visible because the skin there is thin and exposed.

Only for reconstructive indications — congenital length discrepancy, trauma, skeletal dysplasia. Pure cosmetic stature gain is not covered by US, German, or UK insurers at any age.

Yes. Silicone sheets worn 12-23 hours per day from week 4 to month 6 are the best-evidenced over-the-counter scar treatment. Plastic surgery societies treat them as first-line.

Fractional CO2 and pulsed dye laser at 12+ months post-op can soften and lighten scars over a few sessions. It is a meaningful, partial improvement, not a complete erasure.

The skin heals, but each pin site leaves a small permanent round scar. The pattern of dots along the bone remains visible to a trained eye for life.

PRECICE 2 (internal magnetic nail) leaves the fewest — two small linear incisions per leg. No external fixator means no pin sites.

For a patient with realistic expectations, a budget that survives a complication, and a year that can hold the recovery, published evidence shows high satisfaction and a permanent 6–7 cm gain. For someone expecting more than the procedure delivers, or whose real driver is appearance-related distress, it is far more likely to disappoint. The value is personal, but the inputs are knowable.

Yes. Complication rates run 30–45% for cosmetic LL, with 5–15% serious. Budget a $10,000–$30,000 contingency on top of your headline package, or buy a medical-tourism policy that covers complications. A documented case report (PMC11415641, JPRAS Open 2024) showed home-country complication treatment exceeding the original surgery cost.

If your motivation for height is tied to broader distress about your appearance, yes. The orthopedic literature increasingly recommends combining surgery with psychological screening, because satisfaction is not predictable in body dysmorphic disorder — surgery does not resolve distress that was never really about height.

Most patients in published series report high satisfaction, but regret concentrates among those who did not reach their expected height, who experienced a complication, or who had untreated body dysmorphic disorder. Realistic expectations and pre-operative mental-health screening sharply reduce the chance of regret.

A systematic review of cosmetic stature lengthening reported an average gain of about 67 mm (roughly 6–7 cm). A single femur or tibia lengthening typically yields 5–8 cm; gaining 10 cm or more usually requires lengthening a second segment in a separate operation, which doubles cost and recovery.

That is the core of the personal calculation. The gain is permanent; the recovery is a defined 9–18 months. Patients who plan for and can absorb the recovery tend to find the trade acceptable; those who underestimate it are among the less satisfied. Read the realistic timeline before deciding.

Insurance funds medically necessary care. Pure stature gain in a skeletally normal adult does not meet medical-necessity criteria in any national or private system we surveyed, and is excluded by policy language in the same bracket as rhinoplasty and breast augmentation for cosmetic reasons.

Medicare covers reconstructive limb lengthening when the indication is congenital limb-length discrepancy, post-trauma sequela, or skeletal dysplasia documented with imaging. Cosmetic stature gain is statutorily excluded, because cosmetic surgery is not a covered Medicare benefit.

This is the single biggest hidden cost. A 2024 JPRAS Open case report (PMC11415641) documents a patient who needed fixator removal, nail removal, and inpatient care at an Irish ED, the home-country cost dwarfed the original Turkish quote. Always plan for the worst case.

Standard travel insurance does not, most policies explicitly exclude planned cosmetic surgery and any complications. Specialised medical-tourism policies (Global Underwriters, MedjetHorizon) cover planned surgery and complications, running $400–$1,500 for a 6-week trip.

Yes, for the high-volume Istanbul clinics. Turkey's top centers run some of the highest cosmetic-lengthening case loads in the world, and Acibadem and Memorial are JCI-accredited. Safety tracks surgeon volume more than country, pick the surgeon, not the price.

A $24,000 Turkish headline package becomes $32,000–$36,000 once you add implant removal ($3,000), extended physio ($2,000), 4 weeks of hotel ($4,000), flights ($1,500), and a contingency for minor complications. The headline rarely tells the full story.

Most clinics price the lengthening procedure as a separate event from the removal procedure. The removal happens 12–18 months later and is treated as a separate surgical case. Always confirm in writing whether removal is in your quote or extra.

Some plans cover unexpected complications under emergency-care provisions if you have a documented post-op complication after self-funded surgery abroad. The original surgery is almost never reimbursed. Read the policy schedule before you book.

Turkish surgeons mostly use the LON method (external fixator + internal nail), which saves on implant cost. Operating-room overhead in Istanbul is roughly 1/5 of Munich. Malpractice and defensive-medicine costs are a fraction of EU levels.

Yes if you screen the surgeon, not the country. Ask for case volume (target 50+ cases/year), published complication rate with denominator, post-op-overseas complication protocol, and confirmation that implant removal is in the quote.

Turkish clinics typically bundle 4–8 weeks of in-house physiotherapy. US clinics bill it separately. Patients need 9–12 months of physio total, confirm what is bundled and what is your responsibility before you wire the deposit.

Operating-room time costs roughly 5x less in Turkey, malpractice premiums are a fraction of US rates, and Turkish high-volume surgeons run leaner schedules. The implant itself costs the same, about $14,000 for a PRECICE 2 nail.

India is the global floor at $18,000–$30,000 for bilateral femur. Indraprastha Apollo Hospital in New Delhi quotes from $7,500 for a unilateral case. Turkey is the next-cheapest at $22,000–$45,000 with the highest case volume.

The NHS pays for reconstructive cases through the Royal National Orthopaedic Hospital in Stanmore and other specialist centers. Cosmetic patients pay out of pocket, most travel to Turkey or India for the cheaper cash price.

CPT 27466 is femoral lengthening with intramedullary device. CPT 27715 is osteoplasty of the tibia and fibula, lengthening or shortening. CPT 27465 is the femoral-shortening counterpart used in some equalisation strategies.

Indraprastha Apollo Hospital in New Delhi publishes $7,500 for unilateral femur with Ilizarov, the lowest verifiable number in our 44-clinic directory. The Russian Ilizarov Scientific Center in Kurgan quotes from $8,000.

PRECICE 2 removal costs $2,000–$5,000 in Turkey, $1,500–$4,000 in India, $6,000–$15,000 in Germany, and $5,000–$12,000 in the US. The procedure is a one-night hospital stay 12–18 months after the original surgery.

Almost never. Implant removal happens 12–18 months after the original surgery and costs $2,000–$8,000 in Turkey or India and $5,000–$12,000 in the US. Always confirm removal is in your quote before you book.

PRECICE 2 in the US costs $75,000–$160,000 for bilateral femur. The Paley Institute publishes $95,000–$125,000 (approximately $104,500 for bilateral femur). LimbplastX in Las Vegas lists $75,000–$105,000.

The most common serious complications appear inside the first 12 months. Non-union shows on imaging by month 4-6. Nerve injury appears during distraction (weeks 4-10). Deep infection presents inside the first 6 months. Refracture risk peaks during the consolidation phase (months 3-9 post-distraction). By month 18, the outcome is largely settled.

It can be, when performed by an experienced, board-certified surgeon at an accredited facility with a real aftercare plan. The CDC notes that surgery-abroad risk depends on the specific facility, the surgeon, and your health — not the country. A high-volume Istanbul specialist is a very different proposition from a price-led broker clinic.

Often not. Surgery changes the bone, not the underlying self-image, and when the distress is psychological the preoccupation can persist or move to another feature. For appearance-related distress, cognitive behavioural therapy is the evidence-based first-line treatment; addressing the psychology first is what most protects against regret.

Delayed union or non-union is the most common serious complication, affecting roughly 2-8% of cosmetic LL cases across published series. Internal-nail methods cluster at 2-4%; LON and Ilizarov cluster at 6-8%. Risk factors are smoking, distraction faster than 1 mm/day, weight-bearing too soon, low vitamin D, and patient age above 45.

Two layers: general surgery-abroad risks (infection, including drug-resistant and bloodborne, plus the difficulty of getting follow-up care at home) and limb-lengthening-specific risks (bone-union problems, nerve irritation, joint contractures, and pin-site infection with external methods). Most are manageable when caught early.

Limited but generally favourable. The anatomical evidence is that the lengthened bone, once consolidated, behaves like native bone. Late refractures past year 5 are rare. Patients who lengthened beyond 8 cm per segment may carry a slightly higher signal for joint osteoarthritis in middle age, per reconstructive-cohort data.

Roughly 10-15% of cosmetic LL patients show measurable ROM loss at 2 years, almost always in those who interrupted physiotherapy. ROM loss caught at month 4 is largely recoverable; ROM loss persisting to month 12 is harder to reverse. The single biggest preventive lever is consistent physiotherapy through month 9.

Look for Joint Commission International (JCI) accreditation, which signals that a facility meets rigorous, audited international standards for patient safety and infection control. ISO certification is an additional positive signal. Accreditation is the most objective safety indicator available before you travel.

Patients with realistic expectations about the gain and the year-long recovery, a budget that can absorb a complication, and no untreated psychological condition driving the decision tend to report high satisfaction. Those seeking to lift acute distress through the operation are more likely to be disappointed.

Not inherently. Turkey's lower price reflects its healthcare cost base, currency, and high surgical volume — not corner-cutting at reputable centres. The risk is that low headline prices also attract price-led clinics, so the low cost makes verifying the specific surgeon and facility more important, not less.

Once removed at 12-18 months, no. Some patients report mild proprioceptive awareness of the surgical site (a sense of where the bone was lengthened) which fades over the first 2 years. Patients who retain the implant longer than 18 months sometimes report minor sensitivity to cold weather at the implant site.

Before booking, secure a written remote follow-up plan (scheduled video reviews, a named contact, mailed X-ray review) and obtain complete operative notes and implant specifications. The CDC advises travellers to carry a full set of medical records home so a local doctor can provide continuity of care.

Yes, by published rates. PRECICE 2 series report 15-25% any-complication and 2-5% serious. LON reports 25-40% all / 5-10% serious. The difference is pin-site related events. Both are safer at a high-volume surgeon than at a low-volume one — surgeon volume swings the rate more than method choice does.

PRECICE 2 and PRECICE Max are typically removed at 12-18 months post-op once consolidation is complete. Some surgeons leave nails in if removal carries surgical risk. PRECICE Stryde (recalled 2021) requires monitored or elective removal as part of post-recall follow-up — see our Stryde explainer.

Surgical mortality from cosmetic limb lengthening is very low — comparable to other elective orthopaedic procedures — and published cosmetic series generally report no deaths. Deaths in the broader limb lengthening literature involve pediatric reconstructive cases, not cosmetic adult patients.

Corrosion at the telescoping junction of the stainless-steel nail and reports of focal osteolysis (bone loss) and pain adjacent to the implant. A 2021 Bone & Joint Research paper (PMC8333033) found radiographic osteolysis in 35% of segments and macroscopic corrosion in 83% of retrieved nails.

No. Stryde has not been manufactured since 2021 and is not implanted at any clinic in our 44-clinic directory in 2026. NuVasive — now Globus Medical — does not produce the device. Any clinic that still lists Stryde on its method page should be asked directly whether the listing is current.

Yes, in roughly 2-3% of cases. Permanent damage means foot drop from peroneal nerve injury (1-2%), persistent neuropathic pain (1%), or measurable joint range-of-motion loss (1-2%). High-volume surgeons and slower distraction rates (0.75 mm/day) reduce the permanent-injury rate further.

The more responsible centres require or strongly recommend a psychological evaluation before accepting a cosmetic patient. It is there to rule out untreated conditions like body dysmorphic disorder, and it should be read as a sign of a serious, careful clinic rather than an obstacle.

Follow your surgeon's monitoring protocol — typically imaging every 6-12 months for at least 3 years post-op. Most centers in 2026 recommend elective removal once consolidation is complete (12-18 months post-op). Bone healing recovers after explantation in most cases per PMC9221827.

Late refracture (past 24 months) is rare across published series. Most refractures occur between months 6 and 18, when bone density at the lengthened segment has not yet matched native bone. Refractures past year 5 are vanishingly rare in any cohort with that follow-up duration.

Most patients (85-95%) report no chronic pain at 12 months. Chronic pain past year 1 is usually neuropathic — a continuation of a nerve injury during distraction. Permanent neuropathic pain affects 1-2% of cosmetic LL patients. Risk is higher for tibial than femoral lengthening.

None among internal nails. PRECICE 2 and PRECICE Max both require partial weight-bearing during distraction. Patients who specifically need earlier weight-bearing now consider hybrid LON, which uses an external fixator to allow earlier load through the bone-fixator construct.

NuVasive initiated a voluntary field-safety action on February 20, 2021 after surgeon reports surfaced in late 2020 and January 2021. The FDA classified the action as a Class I recall on April 9, 2021. The sequence ran the way the regulatory system is designed to.

During the active lengthening (distraction) phase, expect supervised physiotherapy on the order of 60 to 90 minutes a day, every day, plus your own stretching. The intensity eases as the bone consolidates, but strength and range-of-motion work continues for months. The exact schedule should be confirmed with your clinic and included in the quote.

10 to 15% of patients with poor PT compliance have measurable ROM loss at 2 years — knee flexion deficit, ankle dorsiflexion deficit, hip extension deficit. Equinus contracture in tibial LL requires surgical Achilles release. Hip flexion contracture in femoral LL produces permanent gait alteration.

Tibia (shin) lengthening is generally harder to rehabilitate. It is a tighter compartment with less muscle bulk and a real tendency for the ankle to pull into a toes-down (equinus) position, so it demands especially disciplined ankle and knee work. Femur lengthening usually recovers more smoothly.

It is different from normal muscle ache — burning, electric, or shooting, sometimes with numbness or pins-and-needles. It can signal nerve irritation or compression from rapid distraction. Report it to your surgeon immediately rather than enduring it; rate adjustment usually resolves early cases.

It is uncomfortable, especially during distraction when tissues are under continuous stretch, and stiffness work is often unpleasant. That discomfort is expected and managed alongside your pain plan; the alternative, skipping it, risks permanent stiffness that is far worse long-term.

Yes. Pain fades phase by phase as the bone consolidates and range of motion returns. By the time the new bone is impact-rated and physiotherapy is complete — often 9 to 18 months in — most patients report no ongoing pain. Lingering pain beyond this should be assessed by the surgeon.

Strict bed rest is short — usually only the first days in hospital while acute pain is controlled. Patients then begin moving on crutches with toe-touch weight-bearing. Prolonged bed rest is discouraged because early controlled movement and physiotherapy reduce stiffness and pain.

Yes. Motion lost during lengthening is much harder to regain than to keep, and joint contractures or a fixed ankle position can become permanent if daily physiotherapy is neglected. This is the main reason rehabilitation is treated as non-negotiable rather than optional.

Surgeon-specific protocols vary, and a high-volume surgeon clearing weight-bearing at week 8 instead of week 12 is using their case data, not guesswork. Ask the surgeon for their published or written protocol before booking, and follow that — not a generic timeline.

For many patients, yes. The acute post-op days are sharper but short and heavily medicated, while the distraction weeks bring a sustained, deep ache from muscle and nerve being stretched a millimetre a day. It typically peaks early and eases once lengthening stops.

No high-volume Tier 1 surgeon allows this. Home exercises supplement but do not replace supervised PT. The risk-adjusted outcome — joint contracture, foot drop, refracture from muscle imbalance — is materially worse without a trained physio's hands on the patient.

Generally yes. External fixators (Ilizarov, LON) add pins and wires crossing the skin, which create daily pin-site pain and care on top of the distraction ache. Internal magnetic nails such as PRECICE have no external pins and are associated with less pain.

Yes. PRECICE 2 patients typically reach full weight-bearing at month 4 to 5. LON patients are at month 6 to 8. The nail-only PRECICE design shares load with the regenerate; LON adds an external fixator that lengthens the early weight-bearing void.

Most surgeons clear driving at 8 to 12 weeks for the right (gas-pedal) leg and 4 to 6 weeks for the left leg only, assuming the patient is off opioids and can do an emergency-brake response. Confirm with your operating surgeon.

Walking without aids returns at 4 to 6 months in most internal-nail cases. Full recovery — running, impact sport, implant removal — does not. Clinics that quote 6 months are using the walking milestone, not the functional one.

$80 to $200 per session in the US, €40 to €80 in Western Europe, $25 to $50 in Turkey, $15 to $30 in India. Six months of 4 sessions per week is the standard duration — calculate accordingly when comparing unbundled clinics.

Most do. AFA, Wanna Be Taller, the Yurttaş practice, and LiveLifeTaller all bundle 4 to 8 weeks of in-house PT at twice-daily frequency. Confirm in writing before booking — the bundled hours and supervision quality vary.

Usually no. Bone remodeling slows after 35 and the consolidation phase lengthens by 4 to 8 weeks on average. Complication rates also rise. Surgeon-published age-stratified data is the only reliable benchmark.

Consolidation runs 3 to 6 months after distraction ends. The regenerate is grossly mineralized by month 5 to 6 but cortical density appropriate for impact loading does not appear until month 10 to 14.

Only with crutches and toe-touch on the operated leg. The regenerate is unmineralized tissue and cannot bear structural load. Patients who carry weight in this phase risk regenerate collapse.

Most internal-nail patients are off crutches at month 5 to 6. LON and Ilizarov patients usually transition at month 6 to 8. The trigger is consolidation evidence on imaging, not pain level.

Yes. Daily PT for 9 to 12 months is mandatory at every Tier 1 clinic. Patients who skip it lose permanent range of motion in the knee, ankle, or hip — the literature is unanimous on this.

60 to 90 minutes per day during distraction (weeks 1 to 10). 45 to 60 minutes per day during consolidation (months 3 to 6). 30 to 45 minutes per day during return (months 6 to 12).

Month 9 to 12 on soft surfaces (treadmill, grass, track), once the surgeon confirms cortical density on imaging. Hard-surface running and impact sport come back at month 12 to 15.

Same day or day 1 post-op. Bedside physiotherapy starts within 24 hours, and the patient walks bed-to-chair, then short distances on crutches with toe-touch on the operated leg.

Yes. PRECICE 2's published recovery is 9 to 14 months; LON is 12 to 18. The gap comes from the external fixator and pin sites that LON adds during the distraction phase.

8 to 10 weeks. The phase ends when the surgeon clears the target length on imaging, usually after 60 to 90 days of 1 mm per day distraction.